Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Proteorex Therapeutics

Proteorex Therapeutics
2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$250K LATEST DEAL AMOUNT
4 INVESTORS
Description

Provider of a biotechnology platform created to develop oncology drugs. The company develops oncology drugs using protein-protein interactions (PPIs) between chemical molecule peptides via its proprietary biotechnology platform, enabling physicians and researchers to rapidly and cost-effectively unlock previously undruggable targets.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • MaRS West Tower
  • 661 University Avenue, Suite 1300
  • Toronto, Ontario M5G 0B7
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Proteorex Therapeutics’s full profile, request a free trial.

Proteorex Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 25-May-2017 $250K 0000 Completed Startup
2. Accelerator/Incubator 11-May-2016 0000 Completed Startup
1. Accelerator/Incubator $50K $50K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Proteorex Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
Canadian Technology Accelerator Accelerator/Incubator 000 0000 000000 0
The Next Canada Accelerator/Incubator Minority 000 0000 000000 0

Proteorex Therapeutics Executive Team (5)

Name Title Board
Seat
Contact
Info
Robert Batey Ph.D Co-Founder & Chief Scientific Officer
Marc Adler Co-Founder & Director, Technology
Firhan Malik Ph.D Manager, Finance & Operations
Michael Anstey Ph.D Co-Founder & Chief Operating Officer

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »